M
Monopterostx
monopterostx.com
Website unreachable since Oct 25, 2026
The startup develops inhibitor cells that reprogram regulatory T-cells within the tumor microenvironment to enhance immune responses against solid tumors. Their immunotherapy approach enables cancer patients to achieve a durable immune attack, improving the effectiveness of cancer treatment.
Traction –/10
Boston, United States · HQ
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops inhibitor cells that reprogram regulatory T-cells within the tumor microenvironment to enhance immune responses against solid tumors. Their immunotherapy approach enables cancer patients to achieve a durable immune attack, improving the effectiveness of cancer treatment.